Pod Submissions
Pod Meeting Date Descending | |||||||
|---|---|---|---|---|---|---|---|
| Pod Lead | Hub | Pod Meeting Date | Summary Report | Feedback Topic | SC Discussion | ||
| Vesna Garovic | Mayo Clinic Center for Clinical and Translational Science | November 19, 2024 | -- | -- | |||
Feedback No feedback available. | |||||||
| Arleen Brown | University of California Los Angeles Clinical and Translational Science Institute | October 21, 2024 | -- | -- | |||
Feedback No feedback available. | |||||||
| Randy Urban | University of Texas Medical Branch Institute for Translational Sciences | October 17, 2024 | -- | -- | |||
Feedback No feedback available. | |||||||
| Mimi Kim | Einstein-Montefiore Clinical and Translational Science Award Hub | October 11, 2024 | Questions | -- | |||
Feedback Questions from the Pod for the Steering Committee• Is there any data or information on effectiveness/outcomes of ClinicalTrials.gov policies? | |||||||
| Jennifer Kraschnewski | Penn State Clinical and Translational Science Institute | October 7, 2024 | Questions | -- | |||
Feedback Questions from the Pod for the Steering CommitteeFollowing up on Dr. Rutter's recent RoundTable with the CTSA Hubs, is there any opportunity to invite the ClinicalTrials.gov team/informal work group to a future CTSA meeting to build greater CTSA engagement? | |||||||
| Theodore Wun | UC Davis Clinical and Translational Science Center | October 1, 2024 | -- | -- | |||
Feedback No feedback available. | |||||||
| Theodore Wun | UC Davis Clinical and Translational Science Center | October 1, 2024 | -- | -- | |||
Feedback No feedback available. | |||||||
| Vesna Garovic | Mayo Clinic Center for Clinical and Translational Science | September 26, 2024 | -- | -- | |||
Feedback No feedback available. | |||||||
| Jareen Meinzen-Derr | Cincinnati Center for Clinical and Translational Science and Training | September 25, 2024 | -- | Crowdsourced | -- | ||
Feedback Crowdsourced agenda topic for SCWould like cross-hub communication and with the SC regarding attributions to our CTSIs. What should we "count" and how do we ensure we are transparent about how we are each contributing to innovation. would like a broader discussion on this, especially as we are working on better measuring "impact". would like to learn more about QI and how CTSIs are incorporating this into their processes, how are we fully integrating it and implementing it, and how are we sharing these practices. Would like more about what the RC2 "special sauce" is. Still feel this is a moving target and not enough success stories to fully grasp it | |||||||
| Rosalind Wright | Conduits: Mount Sinai Health System Translational Science Hub | September 20, 2024 | -- | -- | |||
Feedback No feedback available. | |||||||
